Trial intelligence / Profile preview

Pentostatin vs Methotrexate for GVHD Prophylaxis

NCT01188798Phase 3Completed

Sponsor
St. Jude Children's Research Hospital
Start
Sep 2010
Primary completion
Feb 2012
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 3 trial of pentostatin in graft-versus-host disease (GVHD), sponsored by St. Jude Children's Research Hospital. Started Sep 2010; status: completed.

02

Drugs

pentostatin
03

Conditions

graft-versus-host disease (GVHD)

Beyond the preview

Go deeper on NCT01188798.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01188798.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call